HELP     Sign In
Search

Relevance to Autism

KLF7 has been proposed to be a possible candidate gene for phenotypes associated with 2q33.3-q34 deletions, incuding autism spectrum disorder/autistic features (Courtens et al., 1997; Pescucci et al., 2003; Bisgaard et al., 2006; Brandau et al., 2008; Rosenfeld et al., 2010; Jang et al., 2015). Powis et al., 2017 reported 4 unrelated individuals with de novo and potentially damaging missense variants in the KLF7 gene who shared similar clinical features, including developmental delay/intellectual disability, hypotonia, feeding/swallowing issues, psychiatric features, and neuromuscular symptoms; one of these individuals was also diagnosed with autism spectrum disorder. Additional rare de novo non-coding variants in this gene have been observed in ASD probands (Yuen et al., 2016; Yuen et al., 2017; Turner et al., 2017). Tian et al., 2022 reported that klf7 +/- mice exhibited a number of ASD-related behaviors, including deficits in social interaction and repetitive behavior.

Molecular Function

The protein encoded by this gene is a member of the Kruppel-like transcriptional regulator family. Members in this family regulate cell proliferation, differentiation and survival and contain three C2H2 zinc fingers at the C-terminus that mediate binding to GC-rich sites. This protein may contribute to the progression of type 2 diabetes by inhibiting insulin expression and secretion in pancreatic beta-cells and by deregulating adipocytokine secretion in adipocytes. This protein also plays a critical role in neuronal morphogenesis and the survival of sensory neurons.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
De novo variants in KLF7 are a potential novel cause of developmental delay/intellectual disability
DD, ID
ASD, ADD
Support
Chromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett-like features.
DD, epilepsy/seizures
Autistic features, stereotypy
Support
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
ASD
Support
Genome-wide characteristics of de novo mutations in autism
ASD
Support
Interstitial deletion 2q33.3-q34 in a boy with a phenotype resembling the Seckel syndrome
DD, ID
Support
Autistic and Rett-like features associated with 2q33.3-q34 interstitial deletion
DD, ID
Autistic features, stereotypy
Support
Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders.
ASD
Support
Autistic and dysmorphic features associated with a submicroscopic 2q33.3-q34 interstitial deletion detected by array comparative genomic hybridization
DD, ID, epilepsy/seizures
Autistic behavior
Support
Integrating de novo and inherited variants in 42
ASD
Support
Additional chromosomal abnormalities in patients with a previously detected abnormal karyotype, mental retardation, and dysmorphic features
DD, ID
Autistic features
Support
Genomic Patterns of De Novo Mutation in Simplex Autism
ASD
Recent Recommendation
Krüppel-like Transcription Factor 7 Is a Causal Gene in Autism Development
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN1311R001 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN1311R002 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN1311R003 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN1311R004 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN1311R005 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN1311R006 
 copy_number_loss 
  
  
 De novo 
  
 Simplex 
 GEN1311R007 
 missense_variant 
 c.410C>T 
 p.Thr137Met 
 De novo 
  
 Simplex 
 GEN1311R008 
 missense_variant 
 c.790G>A 
 p.Asp264Asn 
 De novo 
  
 Simplex 
 GEN1311R009 
 missense_variant 
 c.415C>T 
 p.Pro139Ser 
 De novo 
  
 Simplex 
 GEN1311R010 
 missense_variant 
 c.410C>T 
 p.Thr137Met 
 De novo 
  
 Simplex 
 GEN1311R011 
 intron_variant 
 n.515-11604G>A 
  
 De novo 
  
 Simplex 
 GEN1311R012 
 intron_variant 
 c.103-10377_103-10367del 
  
 De novo 
  
 Simplex 
 GEN1311R013 
 intron_variant 
 c.531+4993_531+4995del 
  
 De novo 
  
 Multiplex 
 GEN1311R014 
 intron_variant 
 n.576-4471G>A 
  
 De novo 
  
 Simplex 
 GEN1311R015 
 intron_variant 
 n.575+7470G>T 
  
 De novo 
  
 Simplex 
 GEN1311R016 
 3_prime_UTR_variant 
 c.*1606C>T 
  
 De novo 
  
 Simplex 
 GEN1311R017 
 intron_variant 
 n.575+4675G>A 
  
 De novo 
  
 Simplex 
 GEN1311R018 
 missense_variant 
 c.424C>G 
 p.Pro142Ala 
 De novo 
  
  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
2
Duplication
 1
 
2
Duplication
 2
 
2
Duplication
 1
 
2
Duplication
 1
 
2
Deletion
 3
 
2
Deletion
 1
 
2
Deletion-Duplication
 10
 
2
Deletion
 3
 

Model Summary

Klf7 mutant mice displayed abnormal growth, deficits in social interaction, learning and memory, and increased repetitive behavior, but normal olfaction. 631 ASD risk genes are differentially expressed in Klf7 mutant mice. Specifically, Klf7 homozygous mutant mice displayed high mortality of 90% within the first two months, and had severely hypoplastic olfactory bulbs and smaller brains after birth. Mice restored with adeno-associated virus (AAV)-mediated overexpression of Klf7 exhibit restored social interaction and self-grooming behaviors.

References

Type
Title
Author, Year
Primary
Krüppel-like Transcription Factor 7 Is a Causal Gene in Autism Development

M_KLF7_1_CKO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Klf7 conditional ready mice were generated using CRISPR/Cas9 nuclease technology to add loxP sites flanking exon 2. Conditional knockouts were generated by crossing conditional ready mice to mice carrying a Nestin-Cre transgene, resulting in the deletion of exon 2 in neurons, which express Nestin. Mice were kept in a C57BL/6J background.
Allele Type: conditional knockout
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: Cyagen Biosciences Inc.

M_KLF7_2_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Klf7 conditional ready mice were generated using CRISPR/Cas9 nuclease technology to add loxP sites flanking exon 2. Conditional knockouts were generated by crossing conditional ready mice to mice carrying a Nestin-Cre transgene, resulting in the deletion of exon 2 in neurons, which express Nestin. Mice were kept in a C57BL/6J background.
Allele Type: conditional knockout
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: Cyagen Biosciences Inc.

M_KLF7_3_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: A floxed allele of Klf7 was generated by inserting loxP sites on either side of exon 2. Homozygous Klf7 flox/flox mice (MGI:7328579) were then crossed with Emx1-Cre (2684610) mice to generate Klf7flox/+; Emx1-Cre mice, which were further crossed with Klf7flox/flox mice to generate cKO mice.
Allele Type: Conditional knockout
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: Cyagen; Jackson Laboratory

M_KLF7_4_KD_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: IUE was performed with an shRNA targeting KLF7 (shRNA-KLF7) at E14.5. To generate the expression of short hairpin RNAs (shRNAs), two pairs of synthetic oligonucleotides were individually cloned into the pSuper vector (Addgene), in which the shRNAs are under the control of a human H1 promoter.
Allele Type: Knockdown
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_KLF7_1_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Increased
Description: Klf7 heterozygous mutant mice exhibited hyperactivity in the open field test, traveled longer distances, and traveled faster compared to WT mice
 Open field test
 5-6 months
Self grooming1
Increased
Description: Klf7 heterozygous mutant mice spent more time on grooming than WT mice
 Grooming behavior assessments
 5-6 months
Seizures1
Increased
Description: Klf7 heterozygous mutant mice first developed seizures at 4 months of age and peaked around 1 year old when they were slightly hit or squeezed.
 Observation of seizures
 4-12 months
Social memory1
Decreased
Description: Klf7 heterozygous mutant mice showed no preference for interacting with the stranger mouse vs. the familiar mouse compared to WT controls
 Three-chamber social approach test
 5-6 months
Social approach1
Decreased
Description: Klf7 heterozygous mutant mice spent more time in the empty chamber and did not interact with the novel mouse
 Three-chamber social approach test
 5-6 months
Nest building behavior1
Decreased
Description: Klf7 mutant mice showed a poorer nest-building ability, suggesting a social interaction defect
 Nest building assay
 5-6 months
Size/growth1
Decreased
Description: Some Klf7 heterozygous mutant mice exhibited decreased body weight; However, as long as they survived, the mice grew normally.
 General observations
 1 month
Spatial learning1
Decreased
Description: Klf7 heterozygous mutant mice showed a decreased ability to learn on the fifth day, and had more difficulty locating the platform compared to WT controls
 Morris water maze test
 5-6 months
Spatial working memory1
Decreased
Description: Klf7 heterozygous mutant mice preferred the original target arm while WT mice preferred to explore the target arm
 Y-maze test
 5-6 months
Spatial reference memory1
Decreased
Description: Klf7 heterozygous mutant mice spent less time in the target region, and crossed the platform region less frequently compared to WT controls
Exp Paradigm: Probe test
 Morris water maze test
 5-6 months
Gene expression1
Decreased
Description: Klf7 was shown to regulate six high-confidence ASD genes: Shank3, Shank1, Cacna1b, Oxtr, Pcdh10, and Gad2
 Quantitative PCR (qRT-PCR)
 1 month
Differential gene expression1
Abnormal
Description: ASD risk genes are dysregulated in Klf7 heterozygous mutant mice; Of the 228 total Klf7 targeted ASD genes, 43 showed significantly changed expression
 RNA sequencing
 1 month
Targeted expression1
Decreased
Description: A significant decrease in klf7 expression was confirmed in Nestin-Cre conditional knockout mice
Exp Paradigm: Quantitative PCR (qRT-PCR) and Western blot
 Quantitative PCR (qRT-PCR)
 unreported
Exploratory activity1
 No change
 Three-chamber social approach test
 5-6 months
Object recognition memory1
 No change
 Novel object recognition test
 5-6 months
Brain size1
 No change
 Measurement of tissue weight
 0-2 months
Olfaction1
 No change
 Buried food test
 5-6 months
Olfaction1
 No change
 Three-chamber social approach test
 5-6 months
 Not Reported:

M_KLF7_2_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Increased
Description: Klf7 homozygous mutant mice exhibited hyperactivity in the open field test, traveled longer distances, and traveled faster compared to WT mice; Klf7 homozygous mutant mice also exhibited a decreased total resting time
 Open field test
 5-6 months
Brain size1
Decreased
Description: All Klf7 homozygous mutant mice exhibited decreased brain weight
 Measurement of tissue weight
 0-2 months
Olfactory bulb morphology1
Decreased
Description: Klf7 homozygous mutant mice exhibited severely hypoplastic olfactory bulbs after birth; olfactory bulbs of Klf7 homozygous mutant mice were shorter and smaller than those in WT mice
 Macroscopic analysis
 0-2 months
Vertical jumping or back flipping1
Increased
Description: Klf7 homozygous mutant mice exhibited a longtime jumping behavior
 General observations
 5-6 months
Self grooming1
Increased
Description: Klf7 homozygous mutant mice showed the longest grooming time compared with WT mice and Klf7 heterozygous mutant mice
 Grooming behavior assessments
 5-6 months
Social memory1
Decreased
Description: Klf7 homozygous mutant mice showed no preference for interacting with the stranger mouse vs. the familiar mouse compared to WT controls
 Three-chamber social approach test
 5-6 months
Social approach1
Decreased
Description: Klf7 homozygous mutant mice spent more time in the empty chamber and did not interact with the novel mouse
 Three-chamber social approach test
 5-6 months
Nest building behavior1
Decreased
Description: Klf7 mutant mice showed a poorer nest-building ability, suggesting a social interaction defect
 Nest building assay
 5-6 months
Size/growth1
Decreased
Description: All Klf7 homozygous mutant mice exhibited decreased body weight; However, as long as they survived, the mice grew normally.
 General observations
 1 month
Mortality/lethality1
Increased
Description: More than 90% of Klf7 homozygous mutant mice died during the first two months after birth; Klf7 homozygous mutant mice were found to have little or no milk in the stomachs
 General observations
 0-2 months
Exploratory activity1
Decreased
Description: Klf7 homozygous mutant mice show a decreased number of entries into the food-containing chamber during habituation and test phases compared to WT
 Three-chamber social approach test
 5-6 months
Spatial reference memory1
Decreased
Description: Klf7 homozygous mutant mice spent less time in the target region, and crossed the platform region less frequently compared to WT controls
Exp Paradigm: Probe test
 Morris water maze test
 5-6 months
Spatial learning1
Decreased
Description: Klf7 homozygous mutant mice showed obvious learning impairment during the five training periods, and were not able to distinguish the target region at all; Klf7 homozygous mutant mice also had difficulty locating the platform compared to WT controls
 Morris water maze test
 5-6 months
Object recognition memory1
Decreased
Description: Klf7 homozygous mutant mice showed a significantly decreased interaction time ratio and a slightly decreased interaction frequency ratio
Exp Paradigm: interaction time ratio
 Novel object recognition test
 5-6 months
Spatial working memory1
Decreased
Description: Klf7 homozygous mutant mice preferred the original target arm while WT mice preferred to explore the target arm
 Y-maze test
 5-6 months
Targeted expression1
Decreased
Description: A significant decrease in klf7 expression was confirmed in Nestin-Cre conditional knockout mice
Exp Paradigm: Quantitative PCR (qRT-PCR) and Western blot
 Quantitative PCR (qRT-PCR)
 unreported
Olfaction1
 No change
 Buried food test
 5-6 months
Olfaction1
 No change
 Three-chamber social approach test
 5-6 months
 Not Reported:

M_KLF7_3_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Cell proliferation: neural precursors1
Decreased
Description: Klf7 mutant mice exhibited a decrease in the number of cells positive for Tbr2, a marker of intermediate progenitor cells.
Exp Paradigm: Tbr2, marker of intermediate progenitor cells
 Immunostaining
 E12.5, E15.5, E17.5
Neuronal migration1
Decreased
Description: Klf7 mutant mice exhibited a significant decrease in the proportion of EYFP+/Brn2+ cells among EYFP+ cells in the cortical plate compared to controls.
Exp Paradigm: in utero electroporation (IUE) with EYFP
 Immunostaining
 E17.5
Neuronal number1
Decreased
Description: Klf7 mutant mice exhibited decreased numbers of Tuj1+ cells in the cortex compared to controls.
Exp Paradigm: Tuj1, neuronal marker
 Immunostaining
 E12.5, E15.5, E17.5
Astrocyte number1
Decreased
Description: Mutant mice exhibited significantly decreased expression of GFAP, a marker of astrocytes, in the indusium griseum glia (IGG) E17.5 and P1 and the glial wedge (GW) at E17.5. At P7, mutant mice exhibited no change in glial fate differentiation based on the number of cells positive for GFAP and S100β.
Exp Paradigm: GFAP and S100β, markers of astrocytes
 Immunostaining
 E17.5, P1, P7
Morphology and size of the corpus callosum1
Decreased
Description: Pioneer axons that express NF200 were observed in WT mice at E15.5, but the number of NF200+ axons near the midline was significantly reduced in mutant mice compared to controls. Additionally, the number of axons expressing the neural cell adhesion molecule L1, another marker for axonal outgrowth, was significantly reduced in mutant mice compared to controls. At E17.5 and P1, mutant mice exhibited a failure of NF200+ axons to pass through the midline, while controls displayed more orderly pathfinding.
Exp Paradigm: NF200 and L1, marker of axons
 Immunostaining
 E17.5, P1
Neuronal migration1
Decreased
Description: Mutant mice exhibited a significant migration defect among GFP-expressing cells within the cerebral cortex compared to controls.
Exp Paradigm: cortex
 Fluorescence microscopy
 E17.5
Brain size1
Decreased
Description: Mutant mice exhibited decreased brain size compared to controls.
Exp Paradigm: cortex
 Measurement of tissue weight
 P7
Neuronal migration1
Decreased
Description: Klf7 mutant mice exhibited a decrease in the percentage of Tbr1+ cells relative to the total number of cells in layer VI compared to controls.
Exp Paradigm: layer VI
 Immunohistochemistry
 P1
Neuronal morphology1
Abnormal
Description: Mutant mice exhibited a significant increase in cells with multipolar processes in the inner portion of the intermediate zone compared to controls.
Exp Paradigm: in utero electroporation (IUE) with EYFP
 Fluorescence microscopy
 E17.5
Morphology and size of the corpus callosum1
Abnormal
Description: Klf7 mutant mice exhibited a failure of the EYFP+ axon bundles to cross the midline, with most terminating close to the lateral ventricle of the ipsilateral hemisphere. In controls, bundles elongated tangentially along the corpus callosum to the contralateral hemisphere.
Exp Paradigm: in utero electroporation (IUE)
 Fluorescence microscopy
 P16
Neuronal migration1
Increased
Description: Mutant mice exhibited a significant increase in the number of EYFP-expressing cells in the intermediate zone/subventricular zone/ventricular zone compared to controls.
Exp Paradigm: in utero electroporation (IUE) with EYFP
 Fluorescence microscopy
 E17.5
Brain morphology1
Abnormal
Description: Mutant mice exhibited decreased thickness of the neocortex compared to controls.
Exp Paradigm: Nissl staining; cortex
 Histology
 P7
Neuronal migration1
Decreased
Description: Klf7 mutant mice displayed fewer Satb2+/Brn2+ cells in layer II and fewer Ctip2+ cells in layer V compared to controls.
Exp Paradigm: layers II, V
 Immunohistochemistry
 E17.5, P1
Neuronal morphology1
Abnormal
Description: Klf7 mutant mice exhibited disorganized polarity in most of the EYFP-expressing cells in the cortical plate compared to controls.
Exp Paradigm: in utero electroporation (IUE) with pCAG-EYFP plasmid
 Fluorescence microscopy
 P1
Cell proliferation: neural precursors1
Decreased
Description: Klf7 mutant mice exhibited a significant decrease in the percentage of EdU+/EYFP+ cells among all EYFP+ cells in the cortical plate compared to controls. Additionally, the proportion of EdU+/Brn2+ cells among all EdU+ cells in the cortical plate was significantly reduced compared to controls.
Exp Paradigm: in utero electroporation (IUE
 EdU incorporation
 E17.5
Neuronal migration1
Decreased
Description: Klf7 mutant mice exhibited a significantly reduced percentage of EYFP+ cells in the upper layer of the cortex compared to controls, with 30% and 78%, respectively.
Exp Paradigm: in utero electroporation (IUE) with pCAG-EYFP plasmid
 Fluorescence microscopy
 P1
Brain morphology1
Abnormal
Description: Mutant mice exhibited a severe agenesis of the corpus callosum. The fibers of the corpus callosum did not cross the midline, and the anterior commissure was disrupted.
Exp Paradigm: Nissl staining; corpus callosum
 Histology
 P7
Neuronal migration1
Decreased
Description: Klf7 mutant mice displayed fewer Satb2+/ Brn2+ cells in layer II and Satb2+ cells in layers IIâ??IV compared to controls. Additionally, expression of Ctip2 and Tbr1 were dramatically reduced in the neocortex.
Exp Paradigm: layers IIâ??IV
 Immunohistochemistry
 E15.5
Neuronal migration1
Decreased
Description: Mutant mice exhibited significantly fewer EYFP-expressing cells that had migrated into the cortical plate compared to controls.
Exp Paradigm: in utero electroporation (IUE) with EYFP
 Fluorescence microscopy
 E17.5
Differential gene expression1
Abnormal
Description: Klf7 mutant mice exhibited significantly reduced levels of cyclin-dependent kinase inhibitor 1a, a known downstream target of KLF7 involved in neural cytoskeletal remodeling. Additionally, among the downregulated genes related to neuronal migration, one of the most significantly dysregulated genes was rac3, a key regulator of the actin cytoskeleton.
 Quantitative PCR (qRT-PCR)
 P1
Targeted expression1
Decreased
Description: The sagittal brain of mutant mice showed significantly decreased expression of Klf7 in the cortex but similar in the cerebellum compared to controls.
Exp Paradigm: cortex
 In situ hybridization (ISH)
 P7
Differential gene expression1
Abnormal
Description: Klf7 mutant mice exhibited 398 differentially expressed genes, including 103 downregulated genes and 295 upregulated genes, compared to controls. Additionally, gene ontology analysis revealed that enriched terms associated with the downregulated genes were related to cell adhesion and projection during brain development, and that enriched terms associated with the upregulated genes were related to neural development and neurogenesis.
Exp Paradigm: cortex
 RNA sequencing
 P1
Targeted expression1
Decreased
Description: Klf7 mRNA expression level was significantly reduced in the forebrain of mutant mice compared to controls.
Exp Paradigm: forebrain
 Quantitative PCR (qRT-PCR)
 P7
Targeted expression1
Decreased
Description: Klf7 expression in the forebrain was efficiently knocked out in mutant mice compared to controls.
Exp Paradigm: forebrain
 Western blot
 P7
Size/growth1
 No change
 Body weight measurement
 P1â??P150
Cell proliferation: neural precursors1
 No change
 EdU incorporation
 E12.5
Cell proliferation: neural precursors1
 No change
 Immunostaining
 E12.5, E15.5
Cell proliferation: neural precursors1
 No change
 Immunostaining
 E12.5, E15.5
Microglial number1
 No change
 Immunostaining
 E17.5, P1, P7
Neuronal migration1
 No change
 Immunohistochemistry
 E12.5
Neuronal migration1
 No change
 Immunostaining
 E17.5
Number of oligodendrocytes1
 No change
 Immunostaining
 E17.5, P1, P7
Neuronal apoptosis1
 No change
 Immunostaining
 E12.5, E15.5
 Not Reported:

M_KLF7_4_KD_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal migration1
Decreased
Description: Mutant mice exhibited a 19% decrease in the number of GFP-expressing cells in the cortical plate, a 12% increase in cells in the intermediate zone, and a 7% increase in cells in the subventricular zone/ventricular zone. Additionally, mutant mice exhibited a loss of proper radial migration of a subset of the neuronal cells in the cortex.
Exp Paradigm: in utero electroporation (IUE)
 Fluorescence microscopy
 E18.5
 Not Reported:

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.